Cannot prevent disease or transmission, and worsened outcomes for vaccinated against Delta?

IN Popular
  • Updated:1 year ago
  • Reading Time:11Minutes
  • Post Words:2782Words
Print Friendly, PDF & Email

Research valid as at 6 October 2021

Index of Downloadable Refs:
List of Verifiable References



New Evidence Emerging from Highly-Vaccinated Countries

COVID-19 Vaccines: (Delta Data)
Do NOT Prevent COVID-19
Do NOT Reduce viral load
Do NOT Reduce risk of death or hospitalizations

TGA on COVID-19 Vaccines Indicate it’s Provisional Approval is to
“Prevent COVID-19 disease caused by SARS-CoV-2”

The TGA information on the COVID-19 vaccines states that their indication for use is:

“Active immunisation to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV- 2”



COMIRNATY (BNT162b2[mRNA]) COVID-19 Vaccine has provisional approval for the indication below:

Active immunisation to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2, in individuals 12 years of age and older.

The decision has been made on the basis of short term efficacy and safety data. Continued approval depends on the evidence of longer term efficacy and safety from ongoing clinical trials and post-market assessment.

VAXZEVRIA (AstraZeneca)

VAXZEVRIA® (previously COVID-19 Vaccine AstraZeneca) (ChAdOx1-S)

‘VAXZEVRIA has provisional approval for the indication:

Active immunisation of individuals ≥18 years old for the prevention of coronavirus disease
2019 (COVID-19) caused by SARS-CoV-2.

The decision has been made on the basis of short term efficacy and safety data. Continued approval depends on the evidence of longer term efficacy and safety from ongoing clinical trials and post-market assessment.

This statement is now completely inaccurate and outdated as it can be seen globally that these COVID-19 vaccines neither prevent coronavirus disease 2019 (COVID -19) caused by SARS-CoV-2 nor do they prevent transmission of coronavirus disease 2019 (COVID -19 ) caused by SARS-CoV-2.

Increased risk of Hospitalizations and Deaths amongst Vaccinated – Israel

FDA – Advisory Committee – Sept 17, 2021

Israel began a vaccination campaign of Pfizer in December 2020. Over 100-fold decrease in cases following vaccination campaign (in conjunction with partially effective lockdown). Israel reached population-wide immunity (3 months ahead of most countries). Israel is the leading-country for vaccination-rates.

Started seeing Delta in March 2021.
Israel now experiences its highest levels of infection
in spite of widespread (>60% of double-dose vaccination)

Daily cases rose by more than 100-fold in 1.5 months.
(from roughly 12 cases a day to about 1,000).

Severe active cases increased >10 Fold in one month.
60% fully-vaccinated 40% unvaccinated

September 17th 2021

FDA Advisory Committee Meetings (held weekly)

FDA Committee Meeting – YouTube (8 hours)

Twice as High Infections 5-6 months post vaccination in Ages 65 and older

Waning Effect of COVID-19 Vaccines in 5.6M U.S. Study Cohort – U.S. Department of Defense – Project Salus

AI-powered Department of Defense data analysis program named “Project Salus” runs in cooperation with the JAIC (Joint Artificial Intelligence Center) has analyzed data on 5.6 million Medicare beneficiaries aged 65 or older. Data were aggregated from Humetrix, a real-time data and analytics platform that tracks health care outcomes.

The alarming findings show that the vast majority of covid hospitalizations are occurring among fully-vaccinated individuals and that outcomes among the fully vaccinated are growing worse with each passing week. This appears to fit the pattern of so-called Antibody Dependent Enhancement, where the treatment intervention (mRNA vaccines) is worsening health outcomes and leading to excess hospitalizations and deaths. 

The full analysis is entitled, “Effectiveness of mRNA COVID-19 vaccines against the Delta variant among 5.6M Medicare beneficiaries 65 years and older” and is dated Sep. 28, 2021.

Among 5.6 Million Fully-Vaccinated Salus cohort members aged 65 and older (2.7M Pfizer and 2.9M Moderna), as of September 10, 2021:

Vaccine failure dramatically worsens within 5-6 months after being vaccinated

The slide above from the analysis reveals that the infections increase with time, showing a near doubling among those vaccinated 5-6 months ago vs. those vaccinated only 3-4 months ago. These data end at August 21st, 2021 but the trend does not appear to be flattening. As more data are added to this analysis each week, it seems almost certain that breakthrough infections rates will continue to rise over time in vaccinated individuals. We do not yet know what will happen in 9 months after vaccination, but these data show cause for serious concern.

Age only has a minor contribution to the reduced vaccine effectiveness. There is a step-up in risk in ages 75+.

Slide 10

An estimated 60% of hospitalizations occurred in fully-vaccinated individuals in the 65+ years and older group:

Slide 12

In this 80% vaccinated 65+ population, an estimated 60% of COVID-19 hospitalizations occurred in fully vaccinated individuals in the week ending August 7th and by August 21st, 71% of covid-19 “cases” were occurring among fully vaccinated individuals.

These data reveal that as the Delta variant approached a 97% infection rate, “cases” and hospitalizations among fully vaccinated individuals showed striking increases with each passing week.

Risk of hospitalization after vaccine increases with time, doubling at 6 months post-vaccination.

Slide 17

A horrifying slide in the data set reveals that one of the highest risk factors for being hospitalized after being vaccinated is simply being of Native American descent. According to the data in this slide, Native Americans face around 50% higher odds of being hospitalized after being vaccinated, compared to other ethnic groups.

Other factors that greatly increase a person’s odds of being hospitalized after receiving vaccinations include kidney failure (ESRD), morbid obesity, chronic liver disease or receiving chemotherapy.

Natural immunity offers documented protect against future hospitalization

The data shows that natural immunity — listed as “prior covid-19” substantially decreases the risk of hospitalization after receiving covid-19 vaccines. (See slide above.) What this means is that the best way to ensure the safest outcome of a covid vaccine is to experience a covid infection before getting vaccinated. This dramatically reduces your risk of negative health outcomes. Then again, if someone has already had covid, why would they need a vaccine in the first place? If anything, these data show that anyone choosing to receive covid-19 vaccines is making the wrong choice if they desire to avoid infections, hospitalizations or deaths. Natural immunity, once again, is revealed as the most effective status that reduces negative outcomes.

Key findings of the DoD / JAIC / Project Salus / Humetrix analysis

Slide 2

Throughout the slides, “VE” refers to vaccine effectiveness. “Breakthrough” means a failed vaccine, where a fully vaccinated person is diagnosed with covid. Many of those people require hospitalization and ICU treatments. Some of the key findings of the Project Salus analysis include:

  • The effectiveness of mRNA vaccines is confirmed to wane over time.
  • With each passing week, those vaccinated with mRNA vaccines show an increased risk of vaccine failure / covid infections requiring hospitalization. From the analysis: “Odds ratio increasing to 2.5 at 6 months post vaccination.”
  • Natural immunity works: A prior covid infection greatly reduces the odds of a vaccinated person needing hospitalization from a subsequent infection.


These data from the DoD / JAIC show that, in reality, the vast majority of hospitalizations and deaths are occurring among those who are fully vaccinated, according to the 5.6 million people studied in this particular data set (Medicare). Importantly, post-vaccine health outcomes are worsening over time, meaning that the vaccines appear to be gradually damaging the immune system over subsequent months, making vaccinated individuals far more vulnerable to subsequent infections. This is the very definition of ADE (Antibody Dependent Enhancement), about which many analysts and journal publications had pre-warned may happen.

Joint Artificial Intelligence Center
U.S. Department of Defense – Project Salus
Humetrix (Slides) (Updated Weekly Report)

Higher or Similar viral loads – vaccinated vs unvaccinated

The CDC director’s statement about the following study indicates that those who have been vaccinated have higher or similar viral loads as those who are unvaccinated.

Any statement that being vaccinated would reduce viral load or viral transmission is now also inaccurate and outdated based on the most recent reports coming from highly vaccinated populations.

Statement from CDC Director

Referring to study “Covid-19: Fully vaccinated people can carry as much delta virus as unvaccinated people, data indicate“:

Statement from CDC Director

Covid-19: Fully vaccinated people can carry as much delta virus as unvaccinated people, data indicate


Found no significant difference in cycle threshold values between vaccinated and unvaccinated, asymptomatic and symptomatic groups infected with SARS-CoV-2 Delta. Given the substantial proportion of asymptomatic vaccine breakthrough cases with high viral levels, interventions, including masking and testing, should be considered for all in settings with elevated COVID-19 transmission.


No Significant Difference in Viral Load Between Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Groups Infected with SARS-CoV-2 Delta Variant

Fully vaccinated more likely to be infected by “Variants”

The following study from California finds that vaccinated individuals are more susceptible to COVID variant infections than unvaccinated. Among vaccinated individuals, a COVID variant virus is not recognized by the specialized antibodies provided by the vaccine, and the natural antibodies have been programmed to stand down.

In this study, researchers have conducted whole-genome sequencing and measured viral loads from 1,373 COVID-19 infected individuals residing in the San Francisco Bay Area between February 1, 2021, and June 30, 2021, and found:

  • Fully vaccinated were more likely than unvaccinated persons to be infected by variants carrying mutations.
  • Differences in viral loads were non-significant between unvaccinated and fully vaccinated persons overall.
  • Symptomatic vaccinated infections had similar viral loads to unvaccinated infections.

Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California

High Viral Loads in Fully-Vaccinated Healthcare Workers

The following study posted 10th August, 2021 showed that “Delta variant infections in fully vaccinated healthcare workers were associated with high viral loads:

Delta variant infections in fully vaccinated healthcare workers were associated with high viral loads, and indeed were 251 times higher than those in people infected with the original strains.

Transmission of SARS-CoV-2 Delta Variant Among Vaccinated Healthcare Workers, Vietnam

Natural Immunity 13 times stronger than two doses of Pfizer, Israel

August 30th, 2021: Does SARS-CoV-2 natural infection immunity better protect against the Delta variant than vaccination?

Immunity gained naturally better protects against the Delta variant than vaccination.

This study demonstrated that natural immunity confers longer-lasting and stronger protection against infection, symptomatic disease and hospitalization caused by the Delta variant of SARS-CoV-2, compared to the BNT162b2 two-dose vaccine-induced immunity.”

Increased Risk for Symptomatic Infection & Hospitalizations

A new Israeli study (2.5 million patients) on coronavirus immunity suggests that people who were previously infected with the virus benefit from significantly stronger and longer-lasting immunity than the immunity provided by vaccination alone.

Vaccinated individuals had 27 times higher risk of symptomatic COVID infection compared to those with natural infection and were at even greater risk of COVID-19 related hospitalizations compared to those who were previously infected.

The authors concluded that when studying the effects of the Delta Variant, “natural immunity affords longer lasting and stronger protection against infection, symptomatic disease and hospitalization due to the Delta variant of SARS-CoV-2, compared to the BNT162b2 two-dose vaccine-induced immunity.”

Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections

68 Countries : More or No Difference in “Cases” – Fully Vaccinated or Not

“Increases in COVID-19 are unrelated to levels of vaccination across 68 countries and 2947 counties in the United States” – European Journal of Epidemiology September 2021

  • Countries with higher percentage of population fully vaccinated have higher COVID-19 cases per 1 million people.
  • Israel with over 60% of their population fully vaccinated had the highest COVID-19 cases per 1 million people.
  • Comparison of Iceland & Portugal: 75% of their population fully vaccinated & have more COVID-19 cases per 1m people than countries such as Vietnam & South Africa that have around 10% fully vaccinated.
  • Of the top 5 counties that have the highest percentage of population fully vaccinated (99.9–84.3%), the CDC identifies 4 of them as “High” Transmission counties. Chattahoochee (Georgia), McKinley (New Mexico), and Arecibo (Puerto Rico) counties have above 90% of their population fully vaccinated with all three being classified as “High” transmission.
  • Conversely, of the 57 counties that have been classified as “low” transmission counties by the CDC, 26.3% (15) have percentage of population fully vaccinated below 20%.
  • The Ministry of Health in Israel, reported the effectiveness of 2 doses of the BNT162b2 (Pfizer-BioNTech) vaccine against preventing COVID-19 infection was reported to be 39%, substantially lower than the stated trial efficacy of 96%
  • It is also emerging that immunity derived from the Pfizer-BioNTech vaccine may not be as strong as immunity acquired through recovery from the COVID-19 virus.
  • A substantial decline in immunity from mRNA vaccines 6-months post immunization has also been reported.


Subramanian, S.V., Kumar, A. Increases in COVID-19 are unrelated to levels of vaccination across 68 countries and 2947 counties in the United States. Eur J Epidemiol (2021).

Ministry of Health Israel. Two-dose vaccination data. Government of Israel; 2021.

Comparing sars-cov-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections. MedRxiv. 2021.

Significant reduction in humoral Immunity among healthcare workers and nursing home residents 6 months AFTER COVID-19 BNT162b2 mRNA vaccination. MedRxiv. 2021.

Evidence still emerging on efficacy of reduction in infection – AIHW

Current COVID-19 vaccines – according to the Australian Institute of Health and Welfare report on “The first year of COVID-19 in Australia: direct and indirect health effects” released 10th September, 2021, evidence was still emerging on how effectively they reduce infection rates, stop transmission of virus, and initial trials have reduction of disease as their main outcome (rather than reduction in transmission).

Page 13

In other words – these vaccines are not designed to prevent transmission, rather they were designed for preventing disease – which the “emerging evidence” from highly vaccinated populations are now reporting they do not do.

“At the time of writing (September 10th, 2021) “evidence was still emerging on how effectively they reduce infection rates or stop transmission of the virus” and made a point to state that the initial trials had ‘reduction of disease‘ as their main outcome (NOT a reduction in transmission).

Australian Government: Australian Institute of Health and Welfare, Page 13, 10th September, 2021

Risks vs Benefit

Which begs the question of the risk vs benefit of mandating anyone to take a new and fast-tracked experimental medical procedure, implementing new technology, that are still part of a clinical trial, via threat from government that they are “putting the public at risk” – even though their own reports and the latest published studies suggest that these vaccines do not stop the spread – that there is ‘no significant difference’, or the ‘same’ or ‘higher’ viral load whether you are vaccinated or not and which some of the newest publications coming from highly vaccinated populations such as the UK, USA and Israel indicate that those who are vaccinated are having worsened outcomes than those who are unvaccinated.

A recent study found that ~90% of randomly tested healthy adults in British Columbia had evidence of natural immunity to SARS-CoV-2

Mar 15, 2021 A majority of uninfected adults show pre-existing antibody reactivity against SARS-CoV-2

As recently as last week on 22 September 2021 here in Australia at Liverpool Hospital in Sydney:

“The spokesperson said 24 patients and five staff members had been infected in six separate exposure events at the hospital across several wards.” “All staff members who have tested positive for COVID-19 are fully vaccinated,

Penny... on Health
Penny... on Health

Truth-seeker, ever-questioning, ever-learning, ever-researching, ever delving further and deeper, ever trying to 'figure it out'. This site is a legacy of sorts, a place to collect thoughts, notes, book summaries, & random points of interests.

DISCLAIMER: The information on this website is not medical science or medical advice. I do not have any medical training aside from my own research and interest in this area. The information I publish is not intended to diagnose, treat, cure or prevent any disease, disorder, pain, injury, deformity, or physical or mental condition. I just report my own results, understanding & research.